Gujarat Themis Biosyn Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 281.65 million compared to INR 186.04 million a year ago. Revenue was INR 299.71 million compared to INR 192.97 million a year ago. Net income was INR 98.07 million compared to INR 71.21 million a year ago. Basic earnings per share from continuing operations was INR 1.35 compared to INR 0.98 a year ago.
For the nine months, sales was INR 1,208 million compared to INR 860.91 million a year ago. Revenue was INR 1,254.26 million compared to INR 886.32 million a year ago. Net income was INR 462.77 million compared to INR 338.35 million a year ago. Basic earnings per share from continuing operations was INR 6.37 compared to INR 4.658 a year ago.